Radhika Jadhav

TL;DR: Despite the limitations imposed by the suspension of the HPV vaccination, the findings lend support to the WHO recommendation of two doses, at least 6 months apart, for routine vaccination of young girls.

TL;DR: In this article, the authors compared the vaccine efficacy of single dose to that of three and two doses in protecting against persistent HPV 16 and 18 infection at 10 years post vaccination, and concluded that a single dose of vaccine provides similar protection against persistent infection from HPV 16, the genotypes responsible for nearly 70% of cervical cancers, to that provided by two or three doses.

TL;DR: The protection offered by two doses of quadrivalent HPV vaccine against incident and persistent infections in recipients at 15–18 years is comparable to that seen in 3-dose recipients at 10–12 years.

TL;DR: It is found that two doses of HPV vaccine can be extended to girls aged 15–18 years and none of the girls receiving two or three doses had persistent infection from vaccine-targeted types.

TL;DR: In this article , a single-dose quadrivalent vaccine was used to determine whether recipients of a single dose had sustained immune response against targeted HPV types at 10 years post-vaccination and whether this response was superior to the natural antibody titres observed in unvaccinated women.